---
category: news
title: "MD Anderson to use AI to develop cancer drugs through new partnership"
excerpt: "The University of Texas MD Anderson Cancer Center on Monday announced plans to expand its drug development efforts through a partnership with Exscientia, a United Kingdom-based company that uses artificial intelligence to discover new cancer therapies."
publishedDateTime: 2022-11-15T20:42:00Z
originalUrl: "https://www.houstonchronicle.com/news/houston-texas/health/article/MD-Anderson-AI-cancer-drugs-17586908.php"
webUrl: "https://www.houstonchronicle.com/news/houston-texas/health/article/MD-Anderson-AI-cancer-drugs-17586908.php"
type: article

provider:
  name: Houston Chronicle
  domain: houstonchronicle.com

topics:
  - AI in Healthcare
  - AI

secured: "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;OfK7RuOPL0w6dLH52ZkoIw=="
---

